Status:
COMPLETED
Effect of Escalating Doses of a Novel Viscous Polysaccharide on Postprandial Glycemia
Lead Sponsor:
Glycemic Index Laboratories, Inc
Collaborating Sponsors:
InovoBiologic Inc.
Canadian Center for Functional Medicine
Conditions:
Blood Glucose, Postprandial
Eligibility:
All Genders
18-75 years
Phase:
PHASE2
PHASE3
Brief Summary
To determine palatability and extent to which escalating doses of a novel highly viscous polysaccharide \[NVP\] reduces postprandial glycemia when added to a liquid and a solid meal.
Eligibility Criteria
Inclusion
- healthy individuals
- 18-75 years old
- BMI less than 35 kg/m2
Exclusion
- Medications influencing gastrointestinal function
- Pregnancy
Key Trial Info
Start Date :
April 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2006
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00801814
Start Date
April 1 2006
End Date
August 1 2006
Last Update
December 4 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Glycemic Index Laboratories, Inc.
Toronto, Ontario, Canada, M5C 2X3